Evidence map›Paper›PMID 35343812›Full record

ArticleJournal of managed care & specialty pharmacy2022

Bleeding in patients with hemophilia who have inhibitors: Modeling US medical system utilization and cost avoidance between recombinant factor VIIa products with different clinical dosing requirements.

W Allan Alexander, Ivar Jensen, Joanne Hathway, Krutika Srivastava, Philip Cyr, Robert F Sidonio, Katharine Batt

Open access · greenAbstract read
In one paragraph

Article in Journal of managed care & specialty pharmacy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 4 citations in OpenAlex.

  1. Article
  2. Article
  3. Real-world effectiveness of eptacog beta in patients with haemophilia and inhibitors: A multi-institutional case series.Haemophilia : the official journal of the World Federation of Hemophilia · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 2 countries.

W Allan AlexanderIndependent Consultant, Athens.
Ivar JensenPRECISIONheor, Boston, Hathway, MA.
Joanne HathwayPRECISIONheor, Boston, Hathway, MA.
Krutika SrivastavaPRECISIONheor, Boston, Hathway, MA.
Philip CyrPRECISIONheor, Boston, Hathway, MA.
Robert F SidonioDepartment of Pediatrics - Hematology, School of Medicine, Emory University, Atlanta, GA.
Katharine BattIndependent Consultant, Winston-Salem, NC.
Precision for Medicine (United States) · USEmory University · USOldham Council · GBWinston-Salem State University · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Biological ProductsHemophilia AFactor VIIaHemorrhageHumansMaleRecombinant ProteinsUnited StatesBiological ProductsFactor VIIarecombinant FVIIaRecombinant Proteins

Identifiers

PMID35343812
PMCPMC12101516
OpenAlexW4220921050

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.